Cogent Biosciences OverviewCogent Biosciences EBIT
EBIT (Earnings Before Interest and Taxes) analysis for COGT.
Quarterly EBIT
-$104.76M
↓ 39.81% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$367.08M
↓ 27.23% YoY
Trailing 12 months ending Mar 31, 2026
Cogent Biosciences OverviewEBIT (Earnings Before Interest and Taxes) analysis for COGT.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026